These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 27527003)
21. The Effect of Alendronate Loaded Biphasic Calcium Phosphate Scaffolds on Bone Regeneration in a Rat Tibial Defect Model. Park KW; Yun YP; Kim SE; Song HR Int J Mol Sci; 2015 Nov; 16(11):26738-53. PubMed ID: 26561810 [TBL] [Abstract][Full Text] [Related]
22. Functionalization of biomimetic calcium phosphate bone cements with alendronate. Panzavolta S; Torricelli P; Bracci B; Fini M; Bigi A J Inorg Biochem; 2010 Oct; 104(10):1099-106. PubMed ID: 20638728 [TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cells. Magadala P; Amiji M AAPS J; 2008 Dec; 10(4):565-76. PubMed ID: 19034673 [TBL] [Abstract][Full Text] [Related]
24. Improvement of nanoprecipitation technique for preparation of gelatin nanoparticles and potential macromolecular drug loading. Khan SA; Schneider M Macromol Biosci; 2013 Apr; 13(4):455-63. PubMed ID: 23427187 [TBL] [Abstract][Full Text] [Related]
25. Self assembly of DNA nanoparticles with polycations for the delivery of genetic materials into cells. Hosseinkhani H; Tabata Y J Nanosci Nanotechnol; 2006 Aug; 6(8):2320-8. PubMed ID: 17037837 [TBL] [Abstract][Full Text] [Related]
26. Clinical results of alendronate monotherapy and combined therapy with menatetrenone (VitK₂) in postmenopausal RA patients. Suzuki K; Tsuji S; Fukushima Y; Nakase T; Hamada M; Tomita T; Yoshikawa H Mod Rheumatol; 2013 May; 23(3):450-5. PubMed ID: 22692649 [TBL] [Abstract][Full Text] [Related]
29. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization. Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529 [TBL] [Abstract][Full Text] [Related]
30. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments. Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192 [TBL] [Abstract][Full Text] [Related]
31. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer. Thamake SI; Raut SL; Gryczynski Z; Ranjan AP; Vishwanatha JK Biomaterials; 2012 Oct; 33(29):7164-73. PubMed ID: 22795543 [TBL] [Abstract][Full Text] [Related]
32. Construction of amphiphilic copolymer nanoparticles based on gelatin as drug carriers for doxorubicin delivery. Han S; Li M; Liu X; Gao H; Wu Y Colloids Surf B Biointerfaces; 2013 Feb; 102():833-41. PubMed ID: 23107962 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and optimization of gelatin nanoparticles using the miniemulsion process. Ethirajan A; Schoeller K; Musyanovych A; Ziener U; Landfester K Biomacromolecules; 2008 Sep; 9(9):2383-9. PubMed ID: 18666795 [TBL] [Abstract][Full Text] [Related]
34. Improved cisplatin delivery in cervical cancer cells by utilizing folate-grafted non-aggregated gelatin nanoparticles. Dixit N; Vaibhav K; Pandey RS; Jain UK; Katare OP; Katyal A; Madan J Biomed Pharmacother; 2015 Feb; 69():1-10. PubMed ID: 25661330 [TBL] [Abstract][Full Text] [Related]
35. Combinational effect of matrix elasticity and alendronate density on differentiation of rat mesenchymal stem cells. Jiang P; Mao Z; Gao C Acta Biomater; 2015 Jun; 19():76-84. PubMed ID: 25805109 [TBL] [Abstract][Full Text] [Related]
36. A preliminary study on the morphological and release properties of hydroxyapatite-alendronate composite materials. Capra P; Dorati R; Colonna C; Bruni G; Pavanetto F; Genta I; Conti B J Microencapsul; 2011; 28(5):395-405. PubMed ID: 21736524 [TBL] [Abstract][Full Text] [Related]
37. Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research. Elzoghby AO J Control Release; 2013 Dec; 172(3):1075-91. PubMed ID: 24096021 [TBL] [Abstract][Full Text] [Related]
38. Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength. Sakai S; Endo K; Takeda S; Mihara M; Shiraishi A Bone; 2012 May; 50(5):1054-63. PubMed ID: 22366400 [TBL] [Abstract][Full Text] [Related]
39. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment. Allen MR; Burr DB J Bone Miner Res; 2007 Nov; 22(11):1759-65. PubMed ID: 17663638 [TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS). Bhavsar MD; Amiji MM J Control Release; 2007 Jun; 119(3):339-48. PubMed ID: 17475358 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]